Editas Medicine
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Trust87Data Trust: 87/100. Top 25%. Measured by StartupHub.ai. Median 61.A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
Editas Medicine harnesses the power of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases. Their goal is to discover, develop, manufacture, and commercialize transformative, durable genomic medicines for many diseases. They are motivated to deliver these transformative medicines to the greatest number of patients around the world.
Listed competitors
Also in this space
Develops advanced gene editing and cell therapy solutions for rare genetic diseases.
Shares Biotech, MedTech
Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.
Shares CRISPR, Biotech
Developing gene editing therapies to lower cholesterol.
Shares Biotech, MedTech
Scalable, one-time curative in-vivo gene editing therapies.
Shares Biotech, MedTech
Developing gene editing therapies for rare genetic diseases.
Shares Biotech, MedTech
Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.
Shares Biotech, MedTech
Key facts
- Website
- editasmedicine.com
- Headquarters
- Cambridge, United States
- Founded
- 2013
- Employees
- 185
- Total funding
- $210M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Aug 2015 | Series C | $47M | Fidelity Management and Research Company |
| 10 Aug 2015 | Series B | $120M | |
| 1 Nov 2013 | Series A | $43M | Third Rock Ventures, Polaris Partners |
Tech stack
Detected on editasmedicine.com, last scanned 11 Oct 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS, Bootstrap
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Editas Medicine scores 61. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Editas Medicine trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Editas Medicine is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Editas Medicine raised?
Editas Medicine has raised a total of $210M in funding. The most recent round on record is Series C.
How many employees does Editas Medicine have?
Editas Medicine has approximately 185 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Editas Medicine
